Cargando…
Strategies to Extend Thrombolytic Time Window for Ischemic Stroke Treatment: An Unmet Clinical Need
To date, reperfusion with tissue plasminogen activator (tPA) remains the gold standard treatment for ischemic stroke. However, when tPA is given beyond 4.5 hours of stroke onset, deleterious effects of the drug ensue, especially, hemorrhagic transformation (HT), which causes the most significant mor...
Autores principales: | Peña, Ike dela, Borlongan, Cesar, Shen, Guofang, Davis, Willie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Stroke Society
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5307939/ https://www.ncbi.nlm.nih.gov/pubmed/28178410 http://dx.doi.org/10.5853/jos.2016.01515 |
Ejemplares similares
-
Adjunctive Therapy Approaches for Ischemic Stroke: Innovations to Expand Time Window of Treatment
por: Knecht, Talia, et al.
Publicado: (2017) -
Combination therapy for ischemic stroke: Novel approaches to lengthen therapeutic window of tissue plasminogen activator
por: Knecht, Talia, et al.
Publicado: (2018) -
Extension of Tissue Plasminogen Activator Treatment Window by Granulocyte-Colony Stimulating Factor in a Thromboembolic Rat Model of Stroke
por: dela Peña, Ike C., et al.
Publicado: (2018) -
Evolution of the Thrombolytic Treatment Window for Acute Ischemic Stroke
por: Stemer, Andrew, et al.
Publicado: (2010) -
Frequency of thrombolytic targets in stroke patients presenting in an extended time window
por: Heidari, Parisa, et al.
Publicado: (2020)